Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of 4.25 trillion as of March 9, 2026. Its market cap has increased by 63.21% in one year.

Market Cap

4.25T

Enterprise Value

4.72T

Revenue

2.06T

Ranking

n/a

PE Ratio

13.23

Stock Price

2,370.00

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 4.25T, an increase of 380.85%. That is a compound annual growth rate of 4.70%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	4,245.18B	13.23%
Dec 30, 2025	3,749.02B	36.48%
Dec 30, 2024	2,746.92B	-9.13%
Dec 29, 2023	3,022.77B	-17.34%
Dec 30, 2022	3,657.07B	5.52%
Dec 30, 2021	3,465.82B	17.06%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Daiichi Sankyo Company	5,263.97B
Otsuka Holdings	5,309.85B
Ono Pharmaceutical	1,184.64B
Kyowa Kirin	1,178.63B
Chugai Pharmaceutical	15.78T
Santen Pharmaceutical	520.79B
JCR Pharmaceuticals	76.00B
Perseus Proteomics	3.44B

Market Cap Rankings